Latest News About Tiger Woods Dui Medication Subpoena

Here’s what’s currently circulating about Tiger Woods in relation to DUI, medication, and a subpoena as of late April–May 2026.

Direct answer

• Recent reporting indicates Florida prosecutors sought and then obtained a subpoena for Woods’ prescription records as part of the DUI investigation, focusing on what medications were on file, dosages, timing, and warnings that could relate to impairment at the time of the March incident. Woods’ legal team has contested or moved to limit access and has asked for hearings to determine relevance and to impose protective orders on how any records are used. Some outlets note the development as part of prosecutors building a potential case around impairment, even though Woods reportedly posted a 0.00 breath test at the scene and later stepped away from golf for health reasons.

Key developments and context

• Subpoena details: Prosecutors sought prescription data from a Palm Beach pharmacy covering prescriptions from January 1, 2026 through March 27, 2026, including the drug type, pill counts, dosages, instructions, next refill date, and warnings about operating a vehicle. The aim appears to be to correlate medication use with impairment signs observed by officers. This is described in multiple outlets and court filings. A number of reports emphasize the breadth of the subpoena, potentially pulling in extensive personal prescription history. These details are reported by outlets such as sports and entertainment news sites, with some quotes from court documents. [Multiple reports: April–May 2026]

• Legal response: Woods’ attorney has publicly indicated plans to fight the subpoena or seek a hearing to assess relevance, arguing privacy concerns and the need to limit disclosure of personal prescription information. The defense has requested protective orders to govern release and use of any records if the subpoena is upheld. This is presented as a standard legal battle over the scope of discovery in a DUI case. [April 15, 2026 and subsequent coverage]

• Court actions in May 2026: A judge ruled in favor of prosecutors' request to access prescription records, prompting continued arguments from Woods’ side about relevance and privacy. Reports indicate a scheduled or occurred hearing on the matter, with the defense seeking to narrow or guard certain information. [Mid-May 2026 coverage]

• Overall trajectory: The dispute centers on whether prescription records are directly relevant to the DUI investigation and whether they can be used as evidence of impairment, given Woods’ earlier statements and breath test results. News coverage typically frames this as ongoing litigation within the Florida DUI case, rather than a final resolution.

What this means

• If the subpoena stands and records are released, prosecutors could use documented medication details to argue impairment or potential contributing factors at the time of the incident. If the defense succeeds in limiting access or interpretation, the impact on the case could be narrower, focusing on other evidence such as observed impairment signs, field sobriety results, or medical/health context provided by Woods’ treatment plan.

Caveats

• Several outlets rely on court filings or statements from involved parties, and some claims may reflect evolving legal arguments. The specifics of which medications are involved and how they impact the case may become clearer with subsequent court rulings or filings. I can summarize exact court document excerpts if you’d like, or trace the timeline with named sources.

Would you like:

• A concise timeline of the key filings and rulings with source attributions, or
• A plain-language explainer of how prescription records could affect a DUI case, plus what protections a defense attorney might seek?

Note: If you want up-to-the-minute accuracy, I can pull fresh, verified sources and provide direct citations.